102 related articles for article (PubMed ID: 25459751)
1. Alteration of Scn3a expression is mediated via CpG methylation and MBD2 in mouse hippocampus during postnatal development and seizure condition.
Li HJ; Wan RP; Tang LJ; Liu SJ; Zhao QH; Gao MM; Yi YH; Liao WP; Sun XF; Long YS
Biochim Biophys Acta; 2015 Jan; 1849(1):1-9. PubMed ID: 25459751
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Downregulation of Scn3a Expression by Valproate: a Possible Role in Its Anticonvulsant Activity.
Tan NN; Tang HL; Lin GW; Chen YH; Lu P; Li HJ; Gao MM; Zhao QH; Yi YH; Liao WP; Long YS
Mol Neurobiol; 2017 May; 54(4):2831-2842. PubMed ID: 27013471
[TBL] [Abstract][Full Text] [Related]
3. GAPDH-mediated posttranscriptional regulations of sodium channel Scn1a and Scn3a genes under seizure and ketogenic diet conditions.
Lin GW; Lu P; Zeng T; Tang HL; Chen YH; Liu SJ; Gao MM; Zhao QH; Yi YH; Long YS
Neuropharmacology; 2017 Feb; 113(Pt A):480-489. PubMed ID: 27816501
[TBL] [Abstract][Full Text] [Related]
4. Promoter analysis of mouse Scn3a gene and regulation of the promoter activity by GC box and CpG methylation.
Deng GF; Qin JM; Sun XS; Kuang ZY; Su T; Zhao QH; Shi YW; Liu XR; Yu MJ; Yi YH; Liao WP; Long YS
J Mol Neurosci; 2011 Jun; 44(2):115-21. PubMed ID: 21271300
[TBL] [Abstract][Full Text] [Related]
5. SCN3A deficiency associated with increased seizure susceptibility.
Lamar T; Vanoye CG; Calhoun J; Wong JC; Dutton SBB; Jorge BS; Velinov M; Escayg A; Kearney JA
Neurobiol Dis; 2017 Jun; 102():38-48. PubMed ID: 28235671
[TBL] [Abstract][Full Text] [Related]
6. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
7. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
[TBL] [Abstract][Full Text] [Related]
8. Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression.
Ghoshal K; Majumder S; Datta J; Motiwala T; Bai S; Sharma SM; Frankel W; Jacob ST
J Biol Chem; 2004 Feb; 279(8):6783-93. PubMed ID: 14610093
[TBL] [Abstract][Full Text] [Related]
9. Preferential binding of the methyl-CpG binding domain protein 2 at methylated transcriptional start site regions.
Chatagnon A; Perriaud L; Nazaret N; Croze S; Benhattar J; Lachuer J; Dante R
Epigenetics; 2011 Nov; 6(11):1295-307. PubMed ID: 22048253
[TBL] [Abstract][Full Text] [Related]
10. Dynamic expression pattern of Pde4d and its relationship with CpG methylation in the promoter during mouse embryo development.
Huang Z; Han Z; Cui W; Zhang F; He H; Zeng T; Sugimoto K; Wu Q
Biochem Biophys Res Commun; 2013 Nov; 441(4):982-7. PubMed ID: 24220334
[TBL] [Abstract][Full Text] [Related]
11. MDH2 is an RNA binding protein involved in downregulation of sodium channel Scn1a expression under seizure condition.
Chen YH; Liu SJ; Gao MM; Zeng T; Lin GW; Tan NN; Tang HL; Lu P; Su T; Sun WW; Xie LC; Yi YH; Long YS
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1492-1499. PubMed ID: 28433711
[TBL] [Abstract][Full Text] [Related]
12. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of a family of mammalian methyl-CpG binding proteins.
Hendrich B; Bird A
Mol Cell Biol; 1998 Nov; 18(11):6538-47. PubMed ID: 9774669
[TBL] [Abstract][Full Text] [Related]
14. Interstitial 2q24.3 deletion including SCN2A and SCN3A genes in a patient with autistic features, psychomotor delay, microcephaly and no history of seizures.
Celle ME; Cuoco C; Porta S; Gimelli G; Tassano E
Gene; 2013 Dec; 532(2):294-6. PubMed ID: 24080482
[TBL] [Abstract][Full Text] [Related]
15. The "Methyl-CpG Binding Domain protein 2" plays a repressive role in relation to the promoter CpG content in the normal human cell line MRC5.
Perriaud L; Lachuer J; Dante R
Curr Pharm Des; 2014; 20(11):1598-603. PubMed ID: 23888954
[TBL] [Abstract][Full Text] [Related]
16. Methyl-binding domain protein 2-dependent proliferation and survival of breast cancer cells.
Mian OY; Wang SZ; Zhu SZ; Gnanapragasam MN; Graham L; Bear HD; Ginder GD
Mol Cancer Res; 2011 Aug; 9(8):1152-62. PubMed ID: 21693597
[TBL] [Abstract][Full Text] [Related]
17. Tagging methyl-CpG-binding domain proteins reveals different spatiotemporal expression and supports distinct functions.
Wood KH; Johnson BS; Welsh SA; Lee JY; Cui Y; Krizman E; Brodkin ES; Blendy JA; Robinson MB; Bartolomei MS; Zhou Z
Epigenomics; 2016 Apr; 8(4):455-73. PubMed ID: 27066839
[TBL] [Abstract][Full Text] [Related]
18. Reduced mRNA expression levels of MBD2 and MBD3 in gastric carcinogenesis.
Pontes TB; Chen ES; Gigek CO; Calcagno DQ; Wisnieski F; Leal MF; Demachki S; Assumpção PP; Artigiani R; Lourenço LG; Burbano RR; Arruda Cardoso Smith M
Tumour Biol; 2014 Apr; 35(4):3447-53. PubMed ID: 24338710
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region.
Ortmann CA; Burchert A; Hölzle K; Nitsche A; Wittig B; Neubauer A; Schmidt M
Nucleic Acids Res; 2005; 33(21):6895-905. PubMed ID: 16396836
[TBL] [Abstract][Full Text] [Related]
20. Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells.
Chatagnon A; Bougel S; Perriaud L; Lachuer J; Benhattar J; Dante R
Carcinogenesis; 2009 Jan; 30(1):28-34. PubMed ID: 18952593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
